FG 2216
FG 2216 物理性質
- 沸点 :
- 670.6±55.0 °C(Predicted)
- 比重(密度) :
- 1.571±0.06 g/cm3(Predicted)
- 貯蔵温度 :
- -20°C
- 溶解性:
- insoluble in H2O; ≥14.05 mg/mL in DMSO; ≥5.12 mg/mL in EtOH with ultrasonic
- 外見 :
- 粉
- 酸解離定数(Pka):
- 3.20±0.10(Predicted)
- 色:
- 白からベージュ
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
Sigma-Aldrich Japan
|
SML1811 |
≥98% (HPLC)
BIQ ≥98% (HPLC) |
223387-75-5 |
5mg |
¥31000 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
SML1811 |
≥98% (HPLC)
BIQ ≥98% (HPLC) |
223387-75-5 |
25mg |
¥123000 |
2024-03-01 |
購入 |
FG 2216 化学特性,用途語,生産方法
説明
FG-2216 is an inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 (HIF-PH2; IC
50 = 3.9 micromolar). It has been shown to reversibly stimulate erythropoietin secretion at 100 μM
in vitro and to increase hematocrit, red blood cell count, and hemoglobin levels at 50 mg/kg in mice.
使用
FG 2216 is an erythropoietic agent which is orally active prolyl-hydroxylase inhibitor which increases erythropoietin production in end-stage kidney disease.
Biochem/physiol Actions
BIQ (FG-2216) is an orally available and potent inhibitor of prolyl-hydroxylase (PHD). BIQ induces significant and reversible plasma erythropoietin (EPO) levels in vitro and in hemodialysis patients.
FG 2216 上流と下流の製品情報
原材料
準備製品
FG 2216 生産企業
Global( 85)Suppliers
- 223387-75-5
- FG 2216
- FG2216
- FG-2216
- [[(1-Chloro-4-hydroxyisoquinolin-3-yl)carbonyl]amino]acetic acid
- FG 2216 (erythropoietic agent)
- YM 311
- (Z)-2-(((1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)(HYDROXY)METHYLENE)AMINO)ACETIC ACID
- N-[(1-Chloro-4-hydroxy-3-isoquinolinyl)carbonyl]glycine
- (N-(1-chloro-4-hydroxy-isoquinoline-3-carbonyl)-amino)-acetic acid
- FG2216;FG-2216;FG 2216
- Glycine, N-[(1-chloro-4-hydroxy-3-isoquinolinyl)carbonyl]-
- CS-1687
- FG-2216(IOX3
- FG-2216 - YM 311
- BIQ
- 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)acetic acid
- (1-Chloro-4-hydroxyisoquinoline-3-carbonyl)glycine
- IOX-3